Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114164

Inhibition of endotoxin-induced bacterial translocation in mice.

E A Deitch, L Ma, W J Ma, M B Grisham, D N Granger, R D Specian, and R D Berg

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Deitch, E. in: JCI | PubMed | Google Scholar

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Ma, L. in: JCI | PubMed | Google Scholar

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Ma, W. in: JCI | PubMed | Google Scholar

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Grisham, M. in: JCI | PubMed | Google Scholar

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Granger, D. in: JCI | PubMed | Google Scholar

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Specian, R. in: JCI | PubMed | Google Scholar

Department of Surgery, Louisiana State University Medical Center, Shreveport 71130.

Find articles by Berg, R. in: JCI | PubMed | Google Scholar

Published July 1, 1989 - More info

Published in Volume 84, Issue 1 on July 1, 1989
J Clin Invest. 1989;84(1):36–42. https://doi.org/10.1172/JCI114164.
© 1989 The American Society for Clinical Investigation
Published July 1, 1989 - Version history
View PDF
Abstract

The primary functions of the gut are to absorb nutrients and exclude bacteria and their products. However, under certain circumstances the gut may lose its barrier function and serve as a reservoir for systemic microbial infections. These experiments were performed to determine the mechanisms whereby endotoxin causes bacteria to escape (translocate) from the gut. Bacteria translocated from the gut to the mesenteric lymph nodes of mice challenged with nonlethal doses of Escherichia coli 026:B6 or E. coli 0111:B4 endotoxin. Physical disruption of the gut mucosal barrier appears to be the primary mechanism whereby endotoxin promotes bacterial translocation. Mucosal injury and endotoxin-induced bacterial translocation were reduced by inhibition (allopurinol) or inactivation (tung-sten diet) of xanthine oxidase activity (P less than 0.01), but were not affected by the platelet-activation factor antagonists, SRI 63-441 or BN 52021. Because the inhibition or inactivation of xanthine oxidase activity reduced both the extent of mucosal injury and endotoxin-induced bacterial translocation, the effect of endotoxin on the gut appears to be mediated, at least to some degree, by xanthine oxidase-generated, oxygen-free radicals.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 36
page 36
icon of scanned page 37
page 37
icon of scanned page 38
page 38
icon of scanned page 39
page 39
icon of scanned page 40
page 40
icon of scanned page 41
page 41
icon of scanned page 42
page 42
Version history
  • Version 1 (July 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts